Physician-related factors involved in patient decisions to enroll onto cancer clinical trials

Robert L Comis1, Jon D Miller, Diane D Colaizzi

  • 1Coalition of Cancer Cooperative Groups, Philadelphia, PA; and Michigan State University, East Lansing, MI.

Journal of Oncology Practice
|September 22, 2010
PubMed

Insights

Public and cancer survivor attitudes toward clinical trials are key to increasing participation. Understanding these views can help improve access to novel cancer therapies and advance cancer research.

Area of Science:

  • Oncology
  • Clinical Trials
  • Public Health

Background:

  • Developing novel cancer therapies necessitates complex clinical trials.
  • Current adult cancer patient participation in clinical trials remains low, between 3% and 5%.

Purpose of the Study:

  • To identify and understand public and cancer survivor attitudes towards health-related decisions.
  • To determine key factors influencing participation in cancer clinical trials.

Main Methods:

  • Qualitative study exploring patient and public perceptions.
  • Analysis of attitudes towards health decisions and clinical trial enrollment.

Main Results:

  • Low participation rates in cancer clinical trials are linked to specific public and survivor attitudes.
  • Key factors influencing decision-making for trial participation were identified.

Conclusions:

  • Addressing identified attitudes and barriers is crucial for increasing cancer clinical trial enrollment.
  • Enhancing patient and public understanding can improve access to innovative cancer treatments.

Related Concept Videos

Nursing Ethical Principles II01:27

Nursing Ethical Principles II

Ethical principles are essential in guiding nurses to fulfill their responsibilities, focusing on the quality of nursing care and decision-making. These principles, including autonomy, beneficence, non-maleficence, justice, and fidelity, shape the ethical framework within healthcare settings.
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's cancer...
Factors Affecting Protein-Drug Binding: Patient-Related Factors01:29

Factors Affecting Protein-Drug Binding: Patient-Related Factors

Protein-drug binding, a pivotal aspect of pharmacokinetics, is subject to considerable variability influenced by an array of patient-related factors. The intricate interplay of age, individual differences, and pathological conditions significantly impact the binding dynamics and subsequent pharmacological effects.
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...